The CDK4-Arg24Cys (R24C) mutation was also detected in sporadic melanomas [84], suggesting that a CDK4 gene containing this mutation could act as a dominant oncogene that is resistant to normal physiological inhibition by p16INK4A. The gene discussed is CDKN2A; the disease is melanoma.